Monthly Archives: June 2013

The challenges for journalists writing about clinical trials

The challenges for journalists writing about clinical trials
28th June 2013

This article was written by Ruth Francis, Head of Communications at BioMed Central.

Three weeks before this year’s World Conference of Science Journalists (WCSJ) in Helsinki, I was asked to participate in a last minute session on the challenges of reporting clinical trials. At just 40 […]

28th June 2013|

Data sharing – making it real

Data sharing – making it real
26th June 2013

The evidence base for current treatments has been built largely on aggregated results published in journal articles—articles that report trials initiated and sponsored by industry in order to get marketing approval for its products. At last we’re moving towards knowledge based on independent analyses of the original data […]

26th June 2013|

BMA votes that non-publication of trials results is research misconduct

BMA votes that non-publication of trials results is research misconduct

26th June 2013

The British Medical Association has voted to make non-publication of trial results to now be considered research misconduct, and that doctors involved in withholding results should be referred to the General Medical Council. This vote was on a motion tabled at the Annual Representative Meeting. […]

26th June 2013|

European medicines regulator asks for views on access to data

European medicines regulator asks for views on access to data
24th June 2013

The European Medicines Agency has published a first draft of its policy on publication and access to clinical trial data and has asked for comments.

The EMA sets out its position on allowing scrutiny of clinical trial (CT) data: “Access to CT data in an […]

24th June 2013|

Medtronic and Yale open data project

Medtronic and Yale open data project
19th June 2013

US company Medtronic has just heard the results from its groundbreaking project on clinical trial transparency. Two years ago Medtronic gave all the clinical trial data it has for one of its back surgery products to researchers at Yale University. The Yale experts commissioned two groups of researchers […]

19th June 2013|

AllTrials on the BBC Daily Politics today

19th June 2013

Drug firms should publish all of their scientific trials, and not just those they want to put in the public domain, says Dr Ben Goldacre in this short video about the AllTrials campaign.

Dr Ben Goldacre will debate his film in the Daily Politics studio with the Labour’s Emily Thornberry and Conservative Grant Shapps […]

19th June 2013|

Drug companies have a year to publish their data, or we’ll do it for them

17th June 2013

By Tom Jefferson, Cochrane Collaboration

As a doctor it’s my job to prescribe lotions and potions. To do so, I read information about drug trials in books and medical journals to keep me up to speed on the latest drugs, dangers and side effects.

But what if what I read is part of an elaborate […]

19th June 2013|

Negative results in medical research and clinical trials

A brief interview with Dr Ben Goldacre explaining how medical research and patient treatment are affected by the lack of publication of negative data.

You can read the full interview on the F1000Research blog.

19th June 2013|

RIAT initiative for publication of historical clinical trial findings

The RIAT (restoring invisible and abandoned trials) initiative is launched by BMJ, PLOS and researchers today. It is a call to action to companies and academic funders to publish, or update already published, findings from trials they sponsored. The initiators of RIAT say they will make public all the confidential information they hold about missing […]

14th June 2013|

Drug safety relies on people like David tackling the Goliaths of big pharma

10th June 2013

By Edwin Gale, University of Bristol

In 2001 I met David Graham, an official from the US Food and Drug Administration, in a car park in Washington. I wanted him to shed light on why the diabetes drug troglitazone, or Rezulin, had been available in the US and Japan two years after it was […]

12th June 2013|